What is the Fluor (FLR) CFO’s direct share ownership after these trades?

After completing the reported transactions, the CFO directly owned 103,859 shares of Fluor common stock. This figure reflects both the 16,773 shares acquired through option exercise and the 28,762 shares sold in open-market transactions during February 26–27, 2026.

Fluor (NYSE: FLR) CFO exercises options, then sells 28,762 shares

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Fluor Corp chief financial officer John C. Regan reported multiple stock transactions involving company common shares. On February 26, 2026, he exercised employee stock options for 16,773 shares at an exercise price of $17.96 per share, converting them into common stock. Those options had vested in three equal annual installments beginning on March 6, 2022.

He then executed open-market sales of Fluor common stock totaling 28,762 shares across February 26–27, 2026, at reported prices of about $52.74, $51.41, and $52.21 per share. After these trades, he directly owned 103,859 shares of Fluor common stock.

Insider Trade Summary

Net Seller: 28,762 shares ($1,504,062)

Net Sell 5 txns

Insider Regan John C

Role CHIEF FINANCIAL OFFICER

Sold 28,762 shs ($1.50M)

Type	Security	Shares	Price	Value
Sale	Common Stock	8,094	$51.41	$416K
Sale	Common Stock	3,895	$52.21	$203K
Exercise	Employee Stock Option (Right to Buy)	16,773	$0.00	--
Exercise	Common Stock	16,773	$17.96	$301K
Sale	Common Stock	16,773	$52.739	$885K

Holdings After Transaction: Common Stock — 107,754 shares (Direct); Employee Stock Option (Right to Buy) — 0 shares (Direct)

Footnotes (1)

The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.37 to $53.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.96 to $51.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.01 to $52.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The options vested in three equal annual installments beginning on March 6, 2022.

Form 4 Insider Transactions: What Each Field Means →

03/02/2026 - 07:13 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Regan John C

(Last)

(First)

(Middle)

C/O FLUOR CORPORATION

6700 LAS COLINAS BLVD

(Street)

IRVING

75039

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
FLUOR CORP [ FLR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/26/2026		M		16,773	A	$17.96	132,621	D
Common Stock	02/26/2026		S		16,773	D	$52.739⁽¹⁾	115,848	D
Common Stock	02/27/2026		S		8,094	D	$51.41⁽²⁾	107,754	D
Common Stock	02/27/2026		S		3,895	D	$52.21⁽³⁾	103,859	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$17.96	02/26/2026		M			16,773	⁽⁴⁾	03/03/2031	Common Stock	16,773	$0	0	D

Explanation of Responses:

1. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.37 to $53.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

2. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.96 to $51.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.01 to $52.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The options vested in three equal annual installments beginning on March 6, 2022.

	/s/ Nicholas A. Gaspard by Power of Attorney	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Fluor (FLR) CFO John C. Regan report in this Form 4?

Fluor CFO John C. Regan reported exercising employee stock options for 16,773 shares and selling 28,762 common shares in open-market transactions. These trades occurred on February 26–27, 2026, and all holdings were reported as directly owned.

How many Fluor (FLR) shares did the CFO sell and at what prices?

The CFO sold a total of 28,762 Fluor common shares in several open-market transactions. Reported per-share sale prices were approximately $52.74, $51.41, and $52.21, with additional footnotes describing price ranges for the individual trade executions.

Did the Fluor (FLR) CFO exercise stock options in this filing?

Yes. John C. Regan exercised employee stock options covering 16,773 shares of Fluor common stock at an exercise price of $17.96 per share. The options vested in three equal annual installments beginning on March 6, 2022, before being exercised.

Were the Fluor (FLR) CFO’s stock sales open-market transactions?

Yes. Each sale is coded “S” and described as an open-market or private transaction. The filing details three non-derivative common stock sales with specific per-share prices and references weighted-average price ranges disclosed in accompanying footnotes.